Christine Fox, EVP, Head of U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 56,458 shares at $24.78 ($1.4M) on 2025-11-20, disclosed to the SEC on 2025-11-24.
Scheduled sale ($1.4M) by EVP, Head of U.S. Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.78 | 28,229 | $700K | 50.0% |
| 2 | $24.78 | 28,229 | $700K | 50.0% |
| Total | $24.78 avg | 56,458 | $1.4M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $591K | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |
| TEVA | SELL | 2025-03-06 | $161K | — | Filing → |